Literature DB >> 11292882

Evolving antimicrobial chemotherapy for Staphylococcus aureus infections: Our backs to the wall.

R S Daum1, J B Seal.   

Abstract

Staphylococcus aureus is responsible for many nosocomial and community-acquired infections. Its evolving resistance to traditional antimicrobial chemotherapy and emerging prevalence outside of the healthcare environment are serious concerns. This review of the changing epidemiology of methicillin-resistant S. aureus, the emergence of vancomycin (glycopeptide)-resistant isolates, and the mechanisms of resistance to beta-lactams and glycopeptides provides an update for clinicians regarding effective strategies for treatment.

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11292882     DOI： 10.1097/00003246-200104001-00007

Source DB:  PubMed          Journal:  Crit Care Med        ISSN： 0090-3493            Impact factor:   7.598


  9 in total

1.  Single-dose pharmacokinetics and safety of a novel broad-spectrum cephalosporin (BAL5788) in healthy volunteers.

Authors:  Anne Schmitt-Hoffmann; Brigitte Roos; Michael Schleimer; Jill Sauer; Anthony Man; Norman Nashed; Thomas Brown; Antonio Perez; Erhard Weidekamm; Péter Kovács
Journal:  Antimicrob Agents Chemother       Date:  2004-07       Impact factor: 5.191

2.  Use of Monte Carlo simulations to select therapeutic doses and provisional breakpoints of BAL9141.

Authors:  Johan W Mouton; Anne Schmitt-Hoffmann; Stuart Shapiro; Norman Nashed; Nieko C Punt
Journal:  Antimicrob Agents Chemother       Date:  2004-05       Impact factor: 5.191

Review 3.  Acute hematogenous osteomyelitis in children: recognition and management.

Authors:  Andrew C Steer; Jonathan R Carapetis
Journal:  Paediatr Drugs       Date:  2004       Impact factor: 3.022

4.  A high prevalence of methicillin-resistant Staphylococcus aureus among surgically drained soft-tissue infections in pediatric patients.

Authors:  John Seal; Loretto Glynn; Mindy Statter; Donald Liu
Journal:  Pediatr Surg Int       Date:  2006-07-08       Impact factor: 1.827

Review 5.  Community-associated methicillin-resistant Staphylococcus aureus: epidemiology and clinical consequences of an emerging epidemic.

Authors:  Michael Z David; Robert S Daum
Journal:  Clin Microbiol Rev       Date:  2010-07       Impact factor: 26.132

6.  Staphylococcus aureus mutants isolated via exposure to nonfluorinated quinolones: detection of known and unique mutations.

Authors:  S Roychoudhury; T L Twinem; K M Makin; M A Nienaber; C Li; T W Morris; B Ledoussal; C E Catrenich
Journal:  Antimicrob Agents Chemother       Date:  2001-12       Impact factor: 5.191

7.  Evaluation of Pseudomonas aeruginosa staphylolysin (LasA protease) in the treatment of methicillin-resistant Staphylococcus aureus endophthalmitis in a rat model.

Authors:  Irina S Barequet; Zohar Habot-Wilner; Oran Mann; Mary Safrin; Dennis E Ohman; Efrat Kessler; Mordechai Rosner
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2009-03-12       Impact factor: 3.117

8.  Pseudomonas aeruginosa LasA protease in treatment of experimental staphylococcal keratitis.

Authors:  Irina S Barequet; Guy J Ben Simon; Mary Safrin; Dennis E Ohman; Efrat Kessler
Journal:  Antimicrob Agents Chemother       Date:  2004-05       Impact factor: 5.191

9.  Double-disk synergy test for detection of synergistic effect between antibiotics against nosocomial strains of staphylococcus aureus.

Authors:  Rasool Soltani; Hossein Khalili; Fateme Shafiee
Journal:  J Res Pharm Pract       Date:  2012-07
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.